Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?
Brinton
Eliot A
EA
Nanjee
M Nazeem
MN
Hopkins
Paul N
PN
D000787:Angina Pectoris / Q000378:metabolism* / Q000517:prevention & control*; D015415:Biomarkers / Q000097:blood; D008076:Cholesterol, HDL / Q000187:drug effects* / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000187:drug effects* / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000378:metabolism*; D004655:Emulsions; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008066:Lipolysis / Q000187:drug effects* / Q000502:physiology*; D010316:Particle Size; D011379:Prognosis; D014280:Triglycerides / Q000378:metabolism*
D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004655:Emulsions; D000960:Hypolipidemic Agents; D014280:Triglycerides